ExchangeXplorer: an R/Shiny application for processing and visualization of LC–HDX-MS data in metabolomics, lipidomics, and exposomics
Analytica Chimica Acta · 2026
DOI: 10.1016/j.aca.2026.346066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026. Verfasst von Tomas Cajka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, Prague, 14200, Czech Republic. Electronic address: tomas.cajka@fgu.cas.cz. Hauptthemen laut MEDLINE: Metabolomics, Lipidomics, Software, Lipids. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Science Foundation.
Abstract (Originalsprache)
BACKGROUND: Reliable annotation remains a major challenge in untargeted LC-MS-based metabolomics, lipidomics, and exposomics. Liquid chromatography-hydrogen/deuterium exchange-mass spectrometry (LC-HDX-MS) provides orthogonal structural information by revealing the number of exchangeable hydrogens within a molecule, thereby supporting functional-group assignment, distinguishing isomeric structures, and reducing false-positive annotations. However, broader adoption of LC-HDX-MS for small-molecule analysis has been limited by the lack of dedicated software for systematic data processing and interpretation. RESULTS: We developed ExchangeXplorer, an open-source R/Shiny application for processing and visualizing LC-HDX-MS data from small molecules. The software accepts feature tables generated by MS-DIAL, mzmine, and related workflows, automatically pairs unlabeled and HDX-labeled features, calculates deuterium-induced mass shifts, and exports results for downstream annotation. Additional modules provide visualization of paired MS1 and MS/MS spectra, chromatographic validation using extracted ion chromatograms, estimation of exchangeable hydrogens from molecular structures, and generation of m/z-retention time target lists. Evaluation using 163 reference compounds representing metabolites, lipids, pharmaceuticals, and exposome-related chemicals showed that incorporation of experimentally determined exchangeable-hydrogen counts reduced PubChem isomer candidates by an average of 65%. Application to human plasma and serum datasets further demonstrated utility in complex biological matrices. SIGNIFICANCE: ExchangeXplorer provides a dedicated framework for integrating HDX-derived information into untargeted LC-MS annotation workflows, improving confidence in small-molecule characterization and reducing candidate-space complexity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, Prague, 14200, Czech Republic. Electronic address: tomas.cajka@fgu.cas.cz.
- Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, Prague, 14200, Czech Republic.
- West Coast Metabolomics Center, University of California, 451 Health Sciences Drive, Davis, CA, 95616, USA.
Förderung
- Czech Science Foundation
Zitieren
APA
Cajka, T., Hricko, J., Rudl Kulhava, L., Hola, V., Paucova, M., Novakova, M., & Fiehn, O. (2026). ExchangeXplorer: an R/Shiny application for processing and visualization of LC–HDX-MS data in metabolomics, lipidomics, and exposomics. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2026.346066
Vancouver
Cajka T, Hricko J, Rudl Kulhava L, Hola V, Paucova M, Novakova M, et al. ExchangeXplorer: an R/Shiny application for processing and visualization of LC–HDX-MS data in metabolomics, lipidomics, and exposomics. Analytica Chimica Acta. 2026. doi:10.1016/j.aca.2026.346066
BibTeX
@article{Cajka2026,
author = {Cajka, Tomas and Hricko, Jiri and Rudl Kulhava, Lucie and Hola, Veronika and Paucova, Michaela and Novakova, Michaela and Fiehn, Oliver},
title = {ExchangeXplorer: an R/Shiny application for processing and visualization of LC–HDX-MS data in metabolomics, lipidomics, and exposomics},
journal = {Analytica Chimica Acta},
year = {2026},
doi = {10.1016/j.aca.2026.346066}
}
EUVIMED